7:50 am |
Welcome and Announcements
Milind Desai, MD, MBA |
8:00 – 9:00 am |
Session I – State of the Art Prevention and Management
Moderator: Leslie Cho, MD |
|
Pushing the boundaries of lipid lowering: Large new trials to gene therapies
Luke Laffin, MD |
|
Understanding the role of Lp(a) as a CV risk marker in the prevention of CV disease: New trials, when to refer
Leslie Cho, MD |
|
Contemporary management and new trials in hypertension
Luke Laffin, MD |
|
New Data on therapies for obesity, diabetes, kidney metabolic axis: Where research meets the clinic
Leslie Cho, MD |
|
Era of modern preventive coronary imaging: Who, what when and why
Milind Desai, MD, MBA |
|
Panel Discussion/Attendee Q&A
Session Faculty |
9:10 am |
Refreshments & Exhibit Break
|
9:30 – 10:40 am |
Session II – Coronary Artery Disease
Moderator: Gianluca Torregrossa, MD |
|
Discussion about Inoca, Minoca testing and management
Leslie Cho, MD |
|
Decision making in coronary chronic total occlusion - Should we open?
Laura Young, MD |
|
SCAD, anomalies and bridges: How to evaluate and when to refer
Laura Young, MD |
|
Totally Endoscopic Coronary Artery Bypass Grafting: State of the art
Gianluca Torregrossa, MD |
|
Novel concepts in comprehensive surgical management of a patient with ischemic cardiomyopathy?
Michael Tong, MD |
|
Panel Discussion/Attendee Q&A
Session Faculty |
10:40 – 11:40 am |
Session III – Mitral and Tricuspid Valve
Moderator: Samir Kapadia, MD |
|
Modern concepts in multimodality imaging eval of mitral and tricuspid valve disease
Serge Harb, MD |
|
Minimally invasive MV and TV surgical options
Marc Gillinov, MD |
|
Management of complex mitral valve disease (MAC, radiation, infection etc.)
Shinya Unai, MD |
|
Tricuspid and mitral structural interventions: When and how to intervene
Samir Kapadia, MD |
|
Panel Discussion/Attendee Q&A
Session Faculty |
11:40 am |
Lunch
|
12:40 – 2:00 pm |
Session IV – Aortic Valve and aorta
Moderator: Marc Gillinov, MD |
|
Modern concepts in diagnosis of AS and aortopathies and emerging medical therapies
Milind Desai, MD, MBA |
|
TAVR versus SAVR for AS: Latest data
Amar Krishnaswamy, MD |
|
Complex endocarditis surgery including reoperations
Michael Tong, MD |
|
Modern approaches to aortic valve surgery, including for AR, robotic, Ozaki
Shinya Unai, MD |
|
Surgical management of patient with connective tissue disease and inherited aortopathies
Xiaoying Lou, MD |
|
Surgical management of thoracic aortopathies: Grafts to frozen elephant trunks
Shinya Unai, MD |
|
Panel Discussion/Attendee Q&A
Session Faculty |
2:00 pm |
Exhibit Break
|
2:15 – 3:05 pm |
Session V – Electrophysiology
Moderator: Pasquale Santangeli, MD, PhD |
|
A fib ablation: Latest data, new tricks and toys
Oussama Wazni, MD |
|
LAA Closure: Who to refer and management after implantation
Oussama Wazni, MD |
|
Ventricular ablation for arrhythmia
Pasquale Santangeli, MD, PhD |
|
Panel Discussion/Attendee Q&A
Session Faculty |
3:05 – 4:35 pm |
Session VI – Heart Failure and Pericardial
Moderator: Amanda Vest, MBBS, MPH |
|
Management of advanced pericardial disease
Michael Tong, MD |
|
Is this advanced heart failure? When to refer for LVAD/transplant
Michael Tong, MD |
|
HFrEF: Systems approach to GDMT implementation
Amanda Vest, MBBS, MPH |
|
HFpEF: Practical management in the CKM era
Arianne Clare Agdamag, MD |
|
Inherited cardiomyopathies (dilated, restrictive, ARVC): How to evaluate and when to refer
W.H. Wilson Tang, MD |
|
Hypertrophic cardiomyopathy: current concepts and surgical outcomes
Milind Desai, MD, MBA |
|
Amyloid heart disease: Diagnosis and management. New trials and when to refer.
Andres Carmona Rubio, MD |
|
Panel Discussion/Attendee Q&A
Session Faculty |
4:35 pm |
Closing Remarks
|
4:45 pm |
Adjourn to networking reception
|
